Search

Search results

    Michelle Mello — Peering into "Private Time": Medical Schools' Oversight of Faculty Consulting Contracts

    The October 2, 2013, Lab seminar was presented by Michelle Mello, an Edmond J. Safra Lab Fellow and Professor of Law and Public Health at the Harvard School of Public Health. Titled, "Peering into 'Private Time': Medical Schools' Oversight of Faculty Consulting Contracts," Mello's presentation provided a comprehensive overview of her research on policies and practices adopted by medical schools toward their faculty's use of outside time to engage in consulting...

    Read more about Michelle Mello — Peering into "Private Time": Medical Schools' Oversight of Faculty Consulting Contracts

    Should There Be Public Access to Data from Clinical Trials

    by Michelle Mello reblogged from the Robert Wood Johnson Foundation

    For years, pharmaceutical companies have been lambasted in the media and government prosecutions for concealing information about the safety and efficacy of their products. In one particularly splashy example, GlaxoSmithKline (GSK) agreed to pay $3 billion in 2012 to settle criminal charges that it failed to report safety data concerning its antidepressant drug, Paxil, and its diabetes drug, Avandia, and engaged in unlawful marketing of these products and one other drug.... Read more about Should There Be Public Access to Data from Clinical Trials

    When It Comes to Liability and Patient Safety, What's Good for Hospitals Can Be Good for Patients

    by Michelle Mello re-blogged from The Blog of the Huffington Post

    Joanne Doroshaw's blog post on hospital-based communication-and-resolution programs (CRPs) is a stunner—not for its insights about patient safety, but for the suggestion that CRPs are a step in the wrong direction.... Read more about When It Comes to Liability and Patient Safety, What's Good for Hospitals Can Be Good for Patients